Drug Trial Radar · NCT05192369
A Randomized Study to Evaluate the Effects of CTP-543 on the QT/QTc Intervals in Health Volunteers
Last checked: Nov 19, 2026Latest source record: Mar 4, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
48
Actual
Start
Jan 4, 2022
Primary completion
Jan 28, 2022
Study completion Jan 28, 2022
Sponsor
- Lead sponsor
- Concert PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Jan 14, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single (outcomes assessor)
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a four-arm, randomized, crossover, placebo and active controlled study to evaluate of the effect of therapeutic and supratherapeutic doses of CTP-543 on the QT/QTc intervals in healthy volunteers
Conditions
- Healthy Volunteers
Interventions
CTP-543Drug
CTP-543 12 mg (1 x 12 mg tablet), dosed with water
CTP-543Drug
CTP-543 48 mg (4 x 12 mg tablet) dosed with water
MoxifloxacinDrug
Moxifloxacin (1 x 400 mg tablet) dosed with water
PlaceboDrug
Placebo (1 tablet) dosed with water
Primary outcomes
What the sponsor says the trial is designed to measure.
- TQT AnalysisTime frame: Before dosing (pre-dose) through 24 hours post-dose on Day 1, Day 4, Day 7, and Day 10
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Clinical Pharmacology of Miami, LLC
Miami, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.